InvestorsHub Logo
Post# of 4974555
Next 10
Followers 496
Posts 30820
Boards Moderated 2
Alias Born 01/31/2008

Re: i_like_bb_stock post# 4967257

Friday, 05/03/2024 11:36:44 AM

Friday, May 03, 2024 11:36:44 AM

Post# of 4974555
AZTR .22 news catalyst next week : The data will be presented on Friday, May 10, 2024
We are thrilled to announce new preclinical data for our precision dermatology platform that demonstrate proof-of-concept data supporting the use of genetically engineered skin commensals to deliver proteins to the skin,” said Travis Whitfill, Azitra’s co-founder and COO. “These data show the robust preclinical activity of ATR-12 in Netherton syndrome models and further supports the rationale behind our Phase 1b clinical trial in Netherton syndrome patients.”

All posts are my opinion and are not recommendations to buy or sell

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.